Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD

INTRODUCTION: β Blockers are important treatment for ischaemic heart disease and heart failure; however, there has long been concern about their use in people with chronic obstructive pulmonary disease (COPD) due to fear of symptomatic worsening of breathlessness. Despite growing evidence of safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Key, Angela, Parry, Matthew, West, Malcolm A, Asher, Rebecca, Jack, Sandy, Duffy, Nick, Torella, Francesco, Walker, Paul P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387942/
https://www.ncbi.nlm.nih.gov/pubmed/28409004
http://dx.doi.org/10.1136/bmjresp-2016-000164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387942/
https://www.ncbi.nlm.nih.gov/pubmed/28409004
http://dx.doi.org/10.1136/bmjresp-2016-000164

Ejemplares similares